Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1992 Feb;33(2):129–138. doi: 10.1111/j.1365-2125.1992.tb04014.x

Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?

B J Lipworth 1, D G McDevitt 1
PMCID: PMC1381297  PMID: 1347999

Abstract

Conventional low doses of inhaled beta 2-adrenoceptor agonists produce effective bronchodilation without systemic effects. Higher doses of inhaled beta 2-adrenoceptor agonists may produce substantial improvements in bronchodilator response, which may be helpful to patients with more severe airway obstruction. At higher than recommended doses, in asthmatic patients, fenoterol appears to cause greater dose-related systemic beta 2-responses compared with salbutamol or terbutaline, although there is no evidence to suggest that fenoterol is any less beta 2-selective in vivo. Furthermore, tolerance develops to systemic but not to bronchodilator effects during chronic treatment with inhaled beta 2-adrenoceptor agonists. The link between asthma mortality and systemic adverse effects of inhaled beta 2-adrenoceptor agonists at present remains unproven. A critical reappraisal of the regular use of inhaled beta 2-adrenoceptor agonists including long-acting drugs is now indicated in the light of their possible adverse effects on disease control. Patients requiring regular use of inhaled beta 2-adrenoceptor agonists should be given additional anti-inflammatory therapy with inhaled corticosteroids.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold J. M., O'Connor P. C., Riddell J. G., Harron D. W., Shanks R. G., McDevitt D. G. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol. 1985 May;19(5):619–630. doi: 10.1111/j.1365-2125.1985.tb02689.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arvidsson P., Larsson S., Löfdahl C. G., Melander B., Wåhlander L., Svedmyr N. Formoterol, a new long-acting bronchodilator for inhalation. Eur Respir J. 1989 Apr;2(4):325–330. [PubMed] [Google Scholar]
  3. Ask J. A., Stene-Larsen G., Helle K. B., Resch F. Functional beta 1- and beta 2-adrenoceptors in the human myocardium. Acta Physiol Scand. 1985 Jan;123(1):81–88. doi: 10.1111/j.1748-1716.1985.tb07564.x. [DOI] [PubMed] [Google Scholar]
  4. Bristow M. R., Ginsburg R., Umans V., Fowler M., Minobe W., Rasmussen R., Zera P., Menlove R., Shah P., Jamieson S. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 1986 Sep;59(3):297–309. doi: 10.1161/01.res.59.3.297. [DOI] [PubMed] [Google Scholar]
  5. Britton J., Hanley S. P., Garrett H. V., Hadfield J. W., Tattersfield A. E. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax. 1988 Apr;43(4):300–305. doi: 10.1136/thx.43.4.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brodde O. E., Brinkmann M., Schemuth R., O'Hara N., Daul A. Terbutaline-induced desensitization of human lymphocyte beta 2-adrenoceptors. Accelerated restoration of beta-adrenoceptor responsiveness by prednisone and ketotifen. J Clin Invest. 1985 Sep;76(3):1096–1101. doi: 10.1172/JCI112063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brodde O. E., Howe U., Egerszegi S., Konietzko N., Michel M. C. Effect of prednisolone and ketotifen on beta 2-adrenoceptors in asthmatic patients receiving beta 2-bronchodilators. Eur J Clin Pharmacol. 1988;34(2):145–150. doi: 10.1007/BF00614551. [DOI] [PubMed] [Google Scholar]
  8. Brodde O. E., Karad K., Zerkowski H. R., Rohm N., Reidemeister J. C. Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding. Circ Res. 1983 Dec;53(6):752–758. doi: 10.1161/01.res.53.6.752. [DOI] [PubMed] [Google Scholar]
  9. Brodde O. E., O'Hara N., Zerkowski H. R., Rohm N. Human cardiac beta-adrenoceptors: both beta 1- and beta 2-adrenoceptors are functionally coupled to the adenylate cyclase in right atrium. J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1184–1191. [PubMed] [Google Scholar]
  10. Brown M. J., Brown D. C., Murphy M. B. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983 Dec 8;309(23):1414–1419. doi: 10.1056/NEJM198312083092303. [DOI] [PubMed] [Google Scholar]
  11. Cockcroft D. W., Murdock K. Y. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol. 1987 May;79(5):734–740. doi: 10.1016/0091-6749(87)90204-1. [DOI] [PubMed] [Google Scholar]
  12. Collier J. G., Dobbs R. J., Williams I. Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. Br J Clin Pharmacol. 1980 Mar;9(3):273–274. doi: 10.1111/j.1365-2125.1980.tb04837.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Corea L., Bentivoglio M., Verdecchia P., Motolese M., Sorbini C. A., Grassi V., Tantucci C. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation. Clin Pharmacol Ther. 1984 Jun;35(6):776–781. doi: 10.1038/clpt.1984.111. [DOI] [PubMed] [Google Scholar]
  14. Crane J., Burgess C., Beasley R. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax. 1989 Feb;44(2):136–140. doi: 10.1136/thx.44.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Crane J., Pearce N., Flatt A., Burgess C., Jackson R., Kwong T., Ball M., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet. 1989 Apr 29;1(8644):917–922. doi: 10.1016/s0140-6736(89)92505-1. [DOI] [PubMed] [Google Scholar]
  16. Dangman K. H., Danilo P., Jr, Hordof A. J., Mary-Rabine L., Reder R. F., Rosen M. R. Electrophysiologic characteristics of human ventricular and Purkinje fibers. Circulation. 1982 Feb;65(2):362–368. doi: 10.1161/01.cir.65.2.362. [DOI] [PubMed] [Google Scholar]
  17. Deenstra M., Haalboom J. R., Struyvenberg A. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline. Eur J Clin Invest. 1988 Apr;18(2):162–165. doi: 10.1111/j.1365-2362.1988.tb02407.x. [DOI] [PubMed] [Google Scholar]
  18. Gille E., Lemoine H., Ehle B., Kaumann A. J. The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):60–70. doi: 10.1007/BF00498852. [DOI] [PubMed] [Google Scholar]
  19. Grainger J., Woodman K., Pearce N., Crane J., Burgess C., Keane A., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax. 1991 Feb;46(2):105–111. doi: 10.1136/thx.46.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gray B. J., Frame M. H., Costello J. F. A comparative double-blind study of the bronchodilator effects and side effects of inhaled fenoterol and terbutaline administered in equipotent doses. Br J Dis Chest. 1982 Oct;76(4):341–350. doi: 10.1016/0007-0971(82)90068-7. [DOI] [PubMed] [Google Scholar]
  21. Hall J. A., Petch M. C., Brown M. J. Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart. Circ Res. 1989 Sep;65(3):546–553. doi: 10.1161/01.res.65.3.546. [DOI] [PubMed] [Google Scholar]
  22. Hauck R. W., Böhm M., Gengenbach S., Sunder-Plassmann L., Fruhmann G., Erdmann E. Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients. Chest. 1990 Aug;98(2):376–381. doi: 10.1378/chest.98.2.376. [DOI] [PubMed] [Google Scholar]
  23. Heitz A., Schwartz J., Velly J. Beta-adrenoceptors of the human myocardium: determination of beta 1 and beta 2 subtypes by radioligand binding. Br J Pharmacol. 1983 Dec;80(4):711–717. doi: 10.1111/j.1476-5381.1983.tb10062.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Higgins R. M., Cookson W. O., Lane D. J., John S. M., McCarthy G. L., McCarthy S. T. Cardiac arrhythmias caused by nebulised beta-agonist therapy. Lancet. 1987 Oct 10;2(8563):863–864. doi: 10.1016/s0140-6736(87)91057-9. [DOI] [PubMed] [Google Scholar]
  25. Howarth P. H., Durham S. R., Lee T. H., Kay A. B., Church M. K., Holgate S. T. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis. 1985 Nov;132(5):986–992. doi: 10.1164/arrd.1985.132.5.986. [DOI] [PubMed] [Google Scholar]
  26. Inman W. H., Adelstein A. M. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet. 1969 Aug 9;2(7615):279–285. doi: 10.1016/s0140-6736(69)90051-8. [DOI] [PubMed] [Google Scholar]
  27. Jack D. The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists. Br J Clin Pharmacol. 1991 May;31(5):501–514. doi: 10.1111/j.1365-2125.1991.tb05571.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jackson R. T., Beaglehole R., Rea H. H., Sutherland D. C. Mortality from asthma: a new epidemic in New Zealand. Br Med J (Clin Res Ed) 1982 Sep 18;285(6344):771–774. doi: 10.1136/bmj.285.6344.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jeppsson A. B., Löfdahl C. G., Waldeck B., Widmark E. On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration. Pulm Pharmacol. 1989;2(2):81–85. doi: 10.1016/0952-0600(89)90028-8. [DOI] [PubMed] [Google Scholar]
  30. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  31. Kraan J., Koëter G. H., vd Mark T. W., Sluiter H. J., de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol. 1985 Oct;76(4):628–636. doi: 10.1016/0091-6749(85)90786-9. [DOI] [PubMed] [Google Scholar]
  32. Küng M., Croley S. W., Phillips B. A. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol. Influence of mouth rinsing and gargling. Chest. 1987 Mar;91(3):382–387. doi: 10.1378/chest.91.3.382. [DOI] [PubMed] [Google Scholar]
  33. Lai C. K., Twentyman O. P., Holgate S. T. The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness. Am Rev Respir Dis. 1989 Oct;140(4):917–923. doi: 10.1164/ajrccm/140.4.917. [DOI] [PubMed] [Google Scholar]
  34. Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967 May 6;214(5088):597–598. doi: 10.1038/214597a0. [DOI] [PubMed] [Google Scholar]
  35. Larsson S., Svedmyr N. Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics. Am Rev Respir Dis. 1977 Nov;116(5):861–869. doi: 10.1164/arrd.1977.116.5.861. [DOI] [PubMed] [Google Scholar]
  36. Lipworth B. J., Brown R. A., McDevitt D. G. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade. Br J Clin Pharmacol. 1989 Jul;28(1):95–102. doi: 10.1111/j.1365-2125.1989.tb03510.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Lipworth B. J., Clark R. A., Dhillon D. P., Brown R. A., McDevitt D. G. Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol. 1988 Nov;26(5):527–533. doi: 10.1111/j.1365-2125.1988.tb05292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Lipworth B. J., Clark R. A., Dhillon D. P., McDevitt D. G. Comparison of the effects of prolonged treatment with low and high doses of inhaled terbutaline on beta-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1990 Aug;142(2):338–342. doi: 10.1164/ajrccm/142.2.338. [DOI] [PubMed] [Google Scholar]
  39. Lipworth B. J., Clark R. A., Dhillon D. P., McDevitt D. G. Subsensitivity of beta-adrenoceptor responses in asthmatic patients taking regular low dose inhaled salbutamol. Eur J Clin Pharmacol. 1990;38(2):203–205. doi: 10.1007/BF00265986. [DOI] [PubMed] [Google Scholar]
  40. Lipworth B. J., Clark R. A., Dhillon D. P., Moreland T. A., Struthers A. D., Clark G. A., McDevitt D. G. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol. 1989;37(6):567–571. doi: 10.1007/BF00562546. [DOI] [PubMed] [Google Scholar]
  41. Lipworth B. J., Irvine N. A., McDevitt D. G. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol. Eur J Clin Pharmacol. 1991;40(2):135–139. doi: 10.1007/BF00280067. [DOI] [PubMed] [Google Scholar]
  42. Lipworth B. J., McDevitt D. G. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol. 1989;36(3):239–245. doi: 10.1007/BF00558154. [DOI] [PubMed] [Google Scholar]
  43. Löfdahl C. G., Svedmyr N. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration. Allergy. 1989 May;44(4):264–271. doi: 10.1111/j.1398-9995.1989.tb01068.x. [DOI] [PubMed] [Google Scholar]
  44. Maesen F. P., Smeets J. J., Gubbelmans H. L., Zweers P. G. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours. Chest. 1990 Mar;97(3):590–594. doi: 10.1378/chest.97.3.590. [DOI] [PubMed] [Google Scholar]
  45. Maesen F. P., Smeets J. J., Gubbelmans H. L., Zweers P. G. Formoterol in the treatment of nocturnal asthma. Chest. 1990 Oct;98(4):866–870. doi: 10.1378/chest.98.4.866. [DOI] [PubMed] [Google Scholar]
  46. McAlpine L. G., Thomson N. C. Prophylaxis of exercise-induced asthma with inhaled formoterol, a long-acting beta 2-adrenergic agonist. Respir Med. 1990 Jul;84(4):293–295. doi: 10.1016/s0954-6111(08)80056-x. [DOI] [PubMed] [Google Scholar]
  47. McDevitt D. G., Shanks R. G., Swanton J. G. Further observations on the cardiotoxicity of isoprenaline during hypoxia. Br J Pharmacol. 1974 Mar;50(3):335–344. doi: 10.1111/j.1476-5381.1974.tb09608.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Nordrehaug J. E., Johannessen K. A., von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation. 1985 Apr;71(4):645–649. doi: 10.1161/01.cir.71.4.645. [DOI] [PubMed] [Google Scholar]
  49. O'Donnell S. R. An examination of some -adrenoreceptor stimulants for selectivity using the isolated trachea and atria of the guinea pig. Eur J Pharmacol. 1972 Sep;19(3):371–379. doi: 10.1016/0014-2999(72)90104-5. [DOI] [PubMed] [Google Scholar]
  50. O'Donnell S. R., Wanstall J. C. Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol on beta-adrenoceptors in guinea-pig trachea. Eur J Pharmacol. 1978 Feb 1;47(3):333–340. doi: 10.1016/0014-2999(78)90241-8. [DOI] [PubMed] [Google Scholar]
  51. O'Donnell S. R., Wanstall J. C. Potency and selectivity in vitro of compounds related to isoprenaline and orciprenaline on beta-adrenoceptors in the guinea-pig. Br J Pharmacol. 1974 Nov;52(3):407–417. doi: 10.1111/j.1476-5381.1974.tb08610.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Page C. P. One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists. Lancet. 1991 Mar 23;337(8743):717–720. doi: 10.1016/0140-6736(91)90289-2. [DOI] [PubMed] [Google Scholar]
  53. Paterson J. W., Conolly M. E., Davies D. S., Dollery C. T. Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet. 1968 Aug 24;2(7565):426–429. doi: 10.1016/s0140-6736(68)90467-4. [DOI] [PubMed] [Google Scholar]
  54. Pearce N., Grainger J., Atkinson M., Crane J., Burgess C., Culling C., Windom H., Beasley R. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax. 1990 Mar;45(3):170–175. doi: 10.1136/thx.45.3.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Pringle T. H., Riddell J. G., Shanks R. G. Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man. Eur J Clin Pharmacol. 1988;35(5):507–514. doi: 10.1007/BF00558246. [DOI] [PubMed] [Google Scholar]
  56. Reisman R. E. Asthma induced by adrenergic aerosols. J Allergy. 1970 Sep;46(3):162–177. doi: 10.1016/0021-8707(70)90095-x. [DOI] [PubMed] [Google Scholar]
  57. Roden D. M., Iansmith D. H. Effects of low potassium or magnesium concentrations on isolated cardiac tissue. Am J Med. 1987 Mar 20;82(3A):18–23. doi: 10.1016/0002-9343(87)90128-8. [DOI] [PubMed] [Google Scholar]
  58. SURAWICZ B., LEPESCHKIN E., HERRLICH H. C., HOFFMAN B. F. Effect of potassium and calcium deficiency on the monophasic action potential, electrocardiogram and contractility of isolated rabbit hearts. Am J Physiol. 1959 Jun;196(6):1302–1307. doi: 10.1152/ajplegacy.1959.196.6.1302. [DOI] [PubMed] [Google Scholar]
  59. Scheinin M., Koulu M., Laurikainen E., Allonen H. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol. 1987 Nov;24(5):645–653. doi: 10.1111/j.1365-2125.1987.tb03224.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Sears M. R., Rea H. H., Fenwick J., Gillies A. J., Holst P. E., O'Donnell T. V., Rothwell R. P. 75 deaths in asthmatics prescribed home nebulisers. Br Med J (Clin Res Ed) 1987 Feb 21;294(6570):477–480. doi: 10.1136/bmj.294.6570.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Sears M. R., Taylor D. R., Print C. G., Lake D. C., Li Q. Q., Flannery E. M., Yates D. M., Lucas M. K., Herbison G. P. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990 Dec 8;336(8728):1391–1396. doi: 10.1016/0140-6736(90)93098-a. [DOI] [PubMed] [Google Scholar]
  62. Speizer F. E., Doll R., Heaf P., Strang L. B. Investigation into use of drugs preceding death from asthma. Br Med J. 1968 Feb 10;1(5588):339–343. doi: 10.1136/bmj.1.5588.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Stewart D. E., Ikram H., Espiner E. A., Nicholls M. G. Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease. Br Heart J. 1985 Sep;54(3):290–297. doi: 10.1136/hrt.54.3.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Strauss M. H., Reeves R. A., Smith D. L., Leenen F. H. The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist. Clin Pharmacol Ther. 1986 Jul;40(1):108–115. doi: 10.1038/clpt.1986.146. [DOI] [PubMed] [Google Scholar]
  65. Surawicz B. Relationship between electrocardiogram and electrolytes. Am Heart J. 1967 Jun;73(6):814–834. doi: 10.1016/0002-8703(67)90233-5. [DOI] [PubMed] [Google Scholar]
  66. Tandon M. K. Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest. 1980 Mar;77(3):429–431. doi: 10.1378/chest.77.3.429. [DOI] [PubMed] [Google Scholar]
  67. Twentyman O. P., Finnerty J. P., Harris A., Palmer J., Holgate S. T. Protection against allergen-induced asthma by salmeterol. Lancet. 1990 Dec 1;336(8727):1338–1342. doi: 10.1016/0140-6736(90)92894-n. [DOI] [PubMed] [Google Scholar]
  68. Ullman A., Hedner J., Svedmyr N. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Am Rev Respir Dis. 1990 Sep;142(3):571–575. doi: 10.1164/ajrccm/142.3.571. [DOI] [PubMed] [Google Scholar]
  69. Ullman A., Svedmyr N. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax. 1988 Sep;43(9):674–678. doi: 10.1136/thx.43.9.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Vathenen A. S., Knox A. J., Higgins B. G., Britton J. R., Tattersfield A. E. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet. 1988 Mar 12;1(8585):554–558. doi: 10.1016/s0140-6736(88)91352-9. [DOI] [PubMed] [Google Scholar]
  71. WEAVER W. F., BURCHELL H. B. Serum potassium and the electrocardiogram in hypokalemia. Circulation. 1960 Apr;21:505–521. doi: 10.1161/01.cir.21.4.505. [DOI] [PubMed] [Google Scholar]
  72. Wagner J., Reinhardt D., Schümann H. J. Comparison of the bronchodilator and cardiovascular actions of isoprenaline, Th 1165a, terbutaline and salbutamol in cats and isolated organ preparations. Res Exp Med (Berl) 1974;162(1):49–62. doi: 10.1007/BF01851883. [DOI] [PubMed] [Google Scholar]
  73. Wallin A., Melander B., Rosenhall L., Sandström T., Wåhlander L. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma. Thorax. 1990 Apr;45(4):259–261. doi: 10.1136/thx.45.4.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Whicker S. D., Armour C. L., Black J. L. Responsiveness of bronchial smooth muscle from asthmatic patients to relaxant and contractile agonists. Pulm Pharmacol. 1988;1(1):25–31. doi: 10.1016/0952-0600(88)90007-5. [DOI] [PubMed] [Google Scholar]
  75. Whyte K. F., Reid C., Addis G. J., Whitesmith R., Reid J. L. Salbutamol induced hypokalaemia: the effect of theophylline alone and in combination with adrenaline. Br J Clin Pharmacol. 1988 May;25(5):571–578. doi: 10.1111/j.1365-2125.1988.tb03347.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Wilmsmeyer W., Ukena D., Wagner T. O., Sybrecht G. W. First-time treatment with steroids in bronchial asthma: comparison of the effects of inhaled beclomethasone and of oral prednisone on airway function, bronchial reactivity and hypothalamic-pituitary-adrenal axis. Eur Respir J. 1990 Jul;3(7):786–791. [PubMed] [Google Scholar]
  77. Windom H. H., Burgess C. D., Siebers R. W., Purdie G., Pearce N., Crane J., Beasley R. The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma. Clin Pharmacol Ther. 1990 Sep;48(3):296–301. doi: 10.1038/clpt.1990.152. [DOI] [PubMed] [Google Scholar]
  78. Wong C. S., Pavord I. D., Williams J., Britton J. R., Tattersfield A. E. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet. 1990 Dec 8;336(8728):1396–1399. doi: 10.1016/0140-6736(90)93099-b. [DOI] [PubMed] [Google Scholar]
  79. van Schayck C. P., Graafsma S. J., Visch M. B., Dompeling E., van Weel C., van Herwaarden C. L. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol. 1990 Nov;86(5):793–800. doi: 10.1016/s0091-6749(05)80185-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES